JENNIFER PIERCY: Open Payments
NPI 1366155269 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$289 in 11 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $289
Food & beverage: $289
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $158 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Lundbeck LLC | 1 | $21 |
| Alkermes, Inc. | 1 | $19 |
| Noven Therapeutics, LLC | 1 | $16 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
Products named: AUSTEDO XR, Auvelity, ABILIFY MAINTENA, REXULTI, ARISTADA, Xelstrym, ABILIFY ASIMTUFII, INVEGA SUSTENNA.
Industry payments across IN — which companies pay providers there.
